|
Balance Sheet for
Harvard Bioscience Inc.
(HBIO)
|
|
|
|
|
|
|
| Assets
[+]
|
in Thousands of Dollars |
|
|
| Cash and Equivalents |
20,681 |
17,916 |
19,704 |
16,588 |
13,698 |
| Restrictable Cash |
- |
- |
- |
- |
- |
| Marketable Securities |
- |
- |
- |
- |
- |
| Accounts Receivable |
14,357 |
15,078 |
15,440 |
14,383 |
15,086 |
| Loans Receivable |
- |
- |
- |
- |
- |
| Other Receivables |
4,619 |
2,501 |
2,149 |
2,249 |
2,473 |
| Receivables |
18,976 |
17,579 |
17,589 |
16,632 |
17,559 |
| Inventories, Raw Materials |
9,008 |
9,162 |
8,062 |
6,731 |
7,158 |
| Inventories, Work in Progress |
731 |
626 |
596 |
559 |
772 |
| Inventories, Purchased Components |
- |
- |
- |
- |
- |
| Inventories, Finished Goods |
8,023 |
8,372 |
7,174 |
7,116 |
3,971 |
| Inventories, Other |
17,762 |
18,160 |
- |
- |
- |
| Inventories, Adjustments & Allowances |
- |
- |
- |
- |
- |
| Inventories |
17,762 |
18,160 |
15,832 |
14,406 |
11,901 |
| Prepaid Expenses |
- |
- |
- |
- |
- |
| Current Deferred Income Taxes |
1,553 |
3,908 |
5,441 |
573 |
306 |
| Other Current Assets |
- |
- |
- |
- |
- |
| Total Current Assets |
58,972 |
57,563 |
58,566 |
48,199 |
43,464 |
| Land and Improvements |
2,790 |
2,226 |
2,723 |
- |
2,521 |
| Buildings and Improvement |
- |
- |
- |
- |
- |
| Machinery, Furniture and Equipment |
15,072 |
11,156 |
10,432 |
9,985 |
8,849 |
| Construction in Progress |
- |
- |
- |
- |
- |
| Fixed Assets, Other |
- |
- |
- |
2,717 |
- |
| Fixed Assets, Total |
17,862 |
13,382 |
13,155 |
12,702 |
11,370 |
| Gross Fixed Assets |
17,862 |
13,382 |
13,155 |
12,702 |
11,370 |
| Accumulated Depreciation |
(13,311) |
(10,296) |
(10,009) |
(9,157) |
(8,149) |
| Net Fixed Assets |
4,551 |
3,086 |
3,146 |
3,545 |
3,221 |
| Intangibles |
- |
23,636 |
23,184 |
22,405 |
8,955 |
| Cost in Excess |
36,200 |
34,209 |
33,416 |
32,108 |
24,827 |
| Non-Current Deferred Income Taxes |
10,770 |
7,925 |
6,125 |
318 |
238 |
| Other Non-Current Assets |
22,991 |
215 |
360 |
656 |
566 |
| Total Non-Current Assets |
74,512 |
69,071 |
66,231 |
59,032 |
37,807 |
| Total Assets |
133,484 |
126,634 |
124,797 |
107,231 |
81,271 |
|
| Liabilities
[+]
|
in Thousands of Dollars |
|
|
| Accounts Payable |
4,680 |
4,959 |
4,925 |
4,856 |
4,665 |
| Short Term Debt |
- |
- |
- |
- |
- |
| Notes Payable |
- |
- |
- |
13 |
1,361 |
| Accrued Expenses |
3,505 |
3,323 |
- |
- |
4,006 |
| Accrued Liabilities |
3,505 |
3,323 |
4,693 |
3,680 |
427 |
| Deferred Revenues |
482 |
483 |
451 |
434 |
589 |
| Current Deferred Income Taxes |
(731) |
(849) |
- |
- |
- |
| Other Current Liabilities |
1,234 |
794 |
1,227 |
3,275 |
167 |
| Total Current Liabilities |
9,901 |
9,559 |
11,296 |
12,258 |
11,215 |
| Long Term Debt |
12,950 |
16,300 |
18,009 |
13,308 |
59 |
| Deferred Income Tax |
277 |
369 |
954 |
2,037 |
1,216 |
| Other Non-Current Liabilities |
6,143 |
4,907 |
4,290 |
4,371 |
2,063 |
| Minority Interest |
- |
- |
- |
- |
- |
| Capital Lease Obligations |
- |
- |
- |
- |
- |
| Preferred Securities of Subsidiary Trust |
- |
- |
- |
- |
- |
| Preferred Equity Outside Shareholders' Equity |
- |
- |
- |
- |
- |
| Total Non-Current Liabilities |
19,370 |
21,576 |
23,253 |
19,716 |
3,338 |
| Total Liabilities |
29,271 |
31,135 |
34,549 |
31,974 |
14,553 |
| Preferred Shareholder's Equity |
- |
- |
- |
- |
- |
| Common Shareholder's Equity |
104,213 |
95,499 |
90,248 |
75,257 |
66,718 |
| Common Par |
370 |
362 |
361 |
360 |
358 |
| Additional Paid in Capital |
196,634 |
191,157 |
187,893 |
184,856 |
182,073 |
| Cumulative Translation Adjustments |
- |
- |
- |
- |
(1,300) |
| Retained Earnings |
(77,260) |
(79,630) |
(83,442) |
(102,457) |
(109,690) |
| Treasury Stock |
10,668 |
10,668 |
(10,668) |
(5,668) |
(3,264) |
| Other Equity Adjustments |
(4,863) |
(5,722) |
(3,896) |
(1,834) |
(1,459) |
| Total Capitalization |
117,163 |
111,799 |
108,257 |
88,565 |
66,777 |
| Total Equity |
104,213 |
95,499 |
90,248 |
75,257 |
66,718 |
| Total Liabilities & Shareholder's Equity |
133,484 |
126,634 |
124,797 |
107,231 |
81,271 |
| Cash Flow |
(1,888) |
(606) |
23,021 |
10,685 |
4,769 |
| Working Capital |
49,071 |
48,004 |
47,270 |
35,941 |
32,249 |
| Free Cash Flow |
6,293 |
5,142 |
4,334 |
(5,631) |
7,894 |
| Invested Capital |
117,163 |
111,799 |
108,257 |
88,565 |
66,777 |
| Shares Outstanding - Common Class Only |
29,378 |
28,544 |
28,312 |
29,584 |
30,235 |
| Preferred Shares Outstanding |
- |
- |
- |
- |
- |
| Total Ordinary Shares |
29,378 |
28,544 |
- |
- |
- |
| Total Common Shares Outstanding |
29,378 |
28,544 |
28,312 |
29,584 |
30,235 |
| Treasury Shares |
7,746 |
7,746 |
- |
- |
5,552 |
| Basic Weighted Shares Outstanding |
28,799 |
28,451 |
28,967 |
29,649 |
30,882 |
| Diluted Weighted Shares Outstanding |
29,424 |
29,819 |
29,405 |
29,946 |
31,354 |
|
|
|